Skip to main content
ELAN logo

ELAN · Elanco Animal Health Inc · Webcasts, Transcripts & Audio

Track ELAN — free
$22.52 -0.17 (-0.75%) At close · Oct 23
Market Cap
$11.25B
Shares
499.62M
Volume · Oct 23 4.28M Avg daily vol (3M) 6.21M

Elanco Animal Health Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Elanco Animal Health Inc (ELAN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q2
2026-08-05
Elanco Animal Health Inc (ELAN) Q2 2026 Earnings Call Transcript
Confident tone Innovation portfolio and Big Six products U.S. Pet Health growth and omni-channel Farm Animal / Ruminants performance
Revenue
$1.37B
▲ 10.2% YoY
Diluted EPS
$0.11
▲ 450% YoY
Gross margin
58.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-02
Elanco Animal Health Inc (ELAN) June 2, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-06
Elanco Animal Health Inc (ELAN) Q1 2026 Earnings Call Transcript
Confident tone Innovation Products / Big 6 U.S. Pet Health International Pet Health
Revenue
$1.37B
▲ 14.9% YoY
Diluted EPS
$0.11
▼ 15.4% YoY
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Elanco Animal Health Inc (ELAN) Q4 2025 Earnings Call Transcript
Confident tone Innovation / Big Six Products International Expansion U.S. Pet Health
Revenue
$1.14B*
▲ 12.2% YoY
Gross margin
51.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Elanco Animal Health Inc (ELAN) Q3 2025 Earnings Call Transcript
Confident tone Innovation revenue and product portfolio Guidance raise and financial outlook International expansion and Zenrelia global rollout
Revenue
$1.14B
▲ 10.4% YoY
Diluted EPS
$-0.07
▼ 109.6% YoY
Gross margin
53.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Elanco Animal Health Inc (ELAN) Q2 2025 Earnings Call Transcript
Confident tone Innovation Portfolio Performance International Pet Health Farm Animal
Revenue
$1.24B
▲ 4.8% YoY
Diluted EPS
$0.02
Gross margin
57.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Elanco Animal Health Inc (ELAN) Q1 2025 Earnings Call Transcript
Confident tone Innovation and new product launches U.S. pet health and retail trends Farm animal business
Revenue
$1.19B
▼ 1% YoY
Diluted EPS
$0.13
▲ 116.7% YoY
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Elanco Animal Health Inc (ELAN) Q4 2024 Earnings Call Transcript
Confident tone Innovation and Product Launches Revenue Growth and 2025 Guidance Farm Animal Business
Revenue
$1.02B*
▼ 1.4% YoY
Gross margin
50.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Elanco Animal Health Inc (ELAN) Q3 2024 Earnings Call Transcript
Confident tone Innovation Portfolio and New Product Launches Revenue Growth and 2025 Outlook Farm Animal Business
Revenue
$1.03B
▼ 3.6% YoY
Diluted EPS
$0.73
Gross margin
52.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Elanco Animal Health Inc (ELAN) Q2 2024 Earnings Call Transcript
Confident tone Innovation pipeline and product launches U.S. Farm Animal strength U.S. Pet Health performance
Revenue
$1.18B
▲ 12% YoY
Diluted EPS
$-0.10
Gross margin
58.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Elanco Animal Health Inc (ELAN) Q1 2024 Earnings Call Transcript
Confident tone Late-stage pipeline and innovation Guidance and financial outlook Pet Health performance
Revenue
$1.21B
▼ 4.1% YoY
Diluted EPS
$0.06
▼ 71.4% YoY
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-26
Elanco Animal Health Inc (ELAN) Q4 2023 Earnings Call Transcript
Positive tone Innovation pipeline and product launches Pet health business Farm animal business
Revenue
$1.03B*
▲ 5.2% YoY
Gross margin
50.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Elanco Animal Health Inc (ELAN) Q3 2023 Earnings Call Transcript
Revenue
$1.07B
▲ 4.1% YoY
Diluted EPS
$-2.22
Gross margin
54.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Elanco Animal Health Inc (ELAN) Q2 2023 Earnings Call Transcript
Revenue
$1.06B
▼ 10% YoY
Diluted EPS
$-0.20
Gross margin
58.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Elanco Animal Health Inc (ELAN) Q1 2023 Earnings Call Transcript
Revenue
$1.26B
▲ 2.5% YoY
Diluted EPS
$0.21
▲ 110% YoY
Gross margin
60.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-21
Elanco Animal Health Inc (ELAN) Q4 2022 Earnings Call Transcript
Revenue
$984.00M*
▼ 11.5% YoY
Gross margin
54.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Elanco Animal Health Inc (ELAN) Q3 2022 Earnings Call Transcript
Revenue
$1.03B
▼ 9.3% YoY
Diluted EPS
$-0.13
Gross margin
54.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Elanco Animal Health Inc (ELAN) Q2 2022 Earnings Call Transcript
Revenue
$1.18B
▼ 8.1% YoY
Diluted EPS
$-0.02
Gross margin
58.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Elanco Animal Health Inc (ELAN) Q1 2022 Earnings Call Transcript
Revenue
$1.23B
▼ 1.3% YoY
Diluted EPS
$0.10
Gross margin
58.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Elanco Animal Health Inc (ELAN) Q4 2021 Earnings Call Transcript
Revenue
$1.11B
▼ 2.4% YoY
Diluted EPS
$-0.22
Gross margin
53.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-05
Elanco Animal Health Inc (ELAN) Q3 2021 Earnings Call Transcript
Revenue
$1.13B
▲ 27.1% YoY
Diluted EPS
$-0.22
Gross margin
55.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Elanco Animal Health Inc (ELAN) Q2 2021 Earnings Call Transcript
Revenue
$1.28B
▲ 118.3% YoY
Diluted EPS
$-0.42
Gross margin
56.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-07
Elanco Animal Health Inc (ELAN) Q1 2021 Earnings Call Transcript
Revenue
$1.24B
▲ 88.8% YoY
Diluted EPS
$-0.13
Gross margin
54.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Elanco Animal Health Inc (ELAN) Q4 2020 Earnings Call Transcript
Revenue
$1.14B
▲ 44.8% YoY
Gross margin
47.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-06
Elanco Animal Health Inc (ELAN) Q3 2020 Earnings Call Transcript
Revenue
$890.00M
▲ 15.4% YoY
Diluted EPS
$-0.29
▼ 1066.7% YoY
Gross margin
50.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Elanco Animal Health Inc (ELAN) Q2 2020 Earnings Call Transcript
Revenue
$586.00M
▼ 25% YoY
Diluted EPS
$-0.13
▼ 230% YoY
Gross margin
49.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Elanco Animal Health Inc (ELAN) Q1 2020 Earnings Call Transcript
Revenue
$658.00M
▼ 10% YoY
Diluted EPS
$-0.12
▼ 233.3% YoY
Gross margin
49.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-01-10
Elanco Animal Health Inc (ELAN) Q4 2019 Earnings Call
Revenue
$787.00M
▼ 1.5% YoY
Gross margin
47.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 webcasts
Key facts CIK 1739104 CUSIP 28414H103 13F (30d) 105 filings 101 filers Visit website Investor relations